Dr. Suzanne Hill has been Secretary to the WHO Expert Committee on the Selection and Use of Essential Medicines hosted in WHO/HQ Geneva from November 2005 until 2011. In this position she was responsible for developing and updating the WHO Model List of Essential Medicines and providing support to countries in its implementation. She was also team leader for the WHO project on Better Medicines for Children. She chaired the WHO Guideline Review Committee, responsible for quality assurance and standards setting for guideline development within WHO.
Prior to moving to Europe she was Associate Professor in Clinical Pharmacology at the University of Newcastle, Australia where amongst other roles, she was director of a group providing pharmacoeconomics advice to the Pharmaceutical Benefits Advisory Committee of the Australian Department of Health. Her previous experience also includes positions in the Australia drug regulatory authority. Dr Hill's research interests are the public health aspects of clinical pharmacology, including access to medicines and pharmacoeconomics.